Literature DB >> 8215624

Enhancement of crystal induced neutrophil responses by opsonisation of calcium pyrophosphate dihydrate crystals.

H M Burt1, J K Jackson.   

Abstract

OBJECTIVES: Little is known about the effect on crystal induced neutrophil responses of the opsonisation of calcium pyrophosphate dihydrate (CPPD) (triclinic) crystals with components of serum and plasma. The purpose of this study was to determine the effects of precoating CPPD crystals with plasma, serum, complement depleted serum, and IgG on a full range of crystal induced neutrophil responses (calcium mobilisation, chemiluminescence, superoxide anion production, non-cytolytic lysosomal enzyme release, and leukotriene synthesis).
METHODS: Crystals were precoated with IgG, serum, plasma, or complement depleted serum (heated at 56 degrees C), incubated with neutrophils and the responses monitored with time. Measurement of the extent of neutrophil association with crystals was based on monitoring the decrease in fluorescence intensity of supernatants when crystals and diphenylhexatriene labelled neutrophils were allowed to settle under gravity.
RESULTS: Precoating CPPD crystals with IgG, plasma, and serum significantly enhanced chemiluminescence, superoxide anion generation, increases in cytosolic free calcium levels, and non-cytolytic lysosomal enzyme release by neutrophils compared with uncoated CPPD crystals. The enhancement of neutrophil responses by crystals coated with complement depleted serum was less pronounced. The increased neutrophil responses induced by CPPD crystals coated with IgG might have been due to the observed increase in the association of IgG coated crystals with neutrophils.
CONCLUSIONS: These data show that there is a marked potentiation of all neutrophil responses to IgG, plasma, and serum coated CPPD crystals. It is suggested that the adsorption of synovial fluid proteins, including IgG and C3b, to CPPD crystals in vivo, results in the opsonised crystals becoming a potent neutrophil stimulant and inflammatory agent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8215624      PMCID: PMC1005119          DOI: 10.1136/ard.52.8.599

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  27 in total

1.  Differences in the ingestion mechanisms of IgG and C3b particles in phagocytosis by neutrophils.

Authors:  J Hed; O Stendahl
Journal:  Immunology       Date:  1982-04       Impact factor: 7.397

2.  Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis.

Authors:  R Terkeltaub; A J Tenner; F Kozin; M H Ginsberg
Journal:  Arthritis Rheum       Date:  1983-06

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  Protein binding to monosodium urate monohydrate, calcium pyrophosphate dihydrate, and silicon dioxide crystals. I. Physical characteristics.

Authors:  F Kozin; D J McCarty
Journal:  J Lab Clin Med       Date:  1977-06

5.  Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals.

Authors:  R Terkeltaub; L K Curtiss; A J Tenner; M H Ginsberg
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

6.  Monosodium urate monohydrate crystal induced changes in membrane fluidity: a fluorescence polarization study.

Authors:  H M Burt; J K Jackson
Journal:  J Rheumatol       Date:  1988-07       Impact factor: 4.666

7.  Polymorphonuclear leukocyte responses to monosodium urate crystals: modification by adsorbed serum proteins.

Authors:  F Kozin; M H Ginsberg; J L Skosey
Journal:  J Rheumatol       Date:  1979 Sep-Oct       Impact factor: 4.666

8.  Stimulation of the respiratory burst in human neutrophils by crystal phagocytosis.

Authors:  L Simchowitz; J P Atkinson; I Spilberg
Journal:  Arthritis Rheum       Date:  1982-02

9.  Superoxide anion generation by human neutrophils exposed to monosodium urate.

Authors:  S Abramson; S T Hoffstein; G Weissmann
Journal:  Arthritis Rheum       Date:  1982-02

10.  Low density lipoprotein inhibits the physical interaction of phlogistic crystals and inflammatory cells.

Authors:  R Terkeltaub; D Smeltzer; L K Curtiss; M H Ginsberg
Journal:  Arthritis Rheum       Date:  1986-03
View more
  6 in total

1.  Activation of human neutrophils by calcium carbonate polymorphs.

Authors:  H M Burt; J K Jackson; D R Taylor; R S Crowther
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  The interaction of monoclinic calcium pyrophosphate dihydrate crystals with neutrophils.

Authors:  C I Winternitz; J K Jackson; H M Burt
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

3.  Calcium pyrophosphate dihydrate crystals activate MAP kinase in human neutrophils: inhibition of MAP kinase, oxidase activation and degranulation responses of neutrophils by taxol.

Authors:  J K Jackson; C Tudan; B Sahl; S L Pelech; H M Burt
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

4.  Activation of S6 kinase in human neutrophils by calcium pyrophosphate dihydrate crystals: protein kinase C-dependent and phosphatidylinositol-3-kinase-independent pathways.

Authors:  C Tudan; J K Jackson; L Charlton; S L Pelech; B Sahl; H M Burt
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

5.  Response to 'Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4'.

Authors:  Francesca Oliviero; Anna Scanu; Jean-Michel Dayer; Ugo Fiocco; Paolo Sfriso; Leonardo Punzi
Journal:  Arthritis Res Ther       Date:  2012-09-12       Impact factor: 5.156

6.  Inflammatory Potential of Four Different Phases of Calcium Pyrophosphate Relies on NF-κB Activation and MAPK Pathways.

Authors:  Laure Campillo-Gimenez; Félix Renaudin; Maud Jalabert; Pierre Gras; Marjolaine Gosset; Christian Rey; Stéphanie Sarda; Corinne Collet; Martine Cohen-Solal; Christèle Combes; Frédéric Lioté; Hang-Korng Ea
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.